scientific evidence

CEHF’s “Morgellons Arthritis” Article Does Not Say What Its Sources Say

· by
Morgellons arthritis source audit of CEHF claims and cited studies

A closer reading of CEHF’s citations reveals a four-day mouse experiment described as months of joint swelling, an animal study blurred into a human PTLDS diagnosis, and a 6 percent figure whose denominator changes as it moves through the Morgellons literature.

On August 13, 2026, the Charles E. Holman Morgellons Disease Foundation published an official statement warning Morgellons patients about unnamed critics whom it accused of failing to engage properly with peer-reviewed literature and of “nitpicking” researchers. The Foundation urged patients to rely on credible sources and peer-reviewed information while presenting its own work as rooted in scientific integrity.

That is a reasonable standard, and it should apply equally to CEHF. A standing article on the Foundation’s website, Understanding Morgellons Arthritis (archived May 18, 2026), provides an unusually useful test because its claims are specific and its scientific citations can be traced back to the original studies. The article, bylined to Mark Wilcox, was published in December 2022 and last modified February 20, 2023.

Read more

The Closed Loop: When Lyme Advocacy Stops Questioning Itself

by
Lyme disease echo chamber showing doctors, advocates, podcasts, websites and patient groups circulating information inside a closed loop

The Lyme disease community was built, in large part, by people willing to question authority. That history makes the possibility of a Lyme disease echo chamber particularly uncomfortable to discuss. Patients challenged physicians who dismissed symptoms that did not fit established diagnostic categories. Advocates questioned testing standards they believed were inadequate, while researchers pushed against assumptions about diagnosis, treatment, persistence, and coinfections. That willingness to challenge prevailing ideas has often been one of the community’s greatest strengths. It forced difficult conversations and created space for patients who felt abandoned by conventional medicine.

But skepticism only has value when we apply it consistently. A community that demands scrutiny of government agencies, professional societies, insurance companies, and academic medicine should also scrutinize its own physicians, researchers, laboratories, advocacy organizations, websites, podcasts, and influential personalities. We cannot insist that outside institutions tolerate uncomfortable questions while treating the same questions differently when they point inward. Skepticism stops functioning as a method when it depends on who receives it.

Read more

Why Did Two Morgellons Studies Point Toward Helicobacter?

· by
Scientific featured image comparing a 2019 targeted Morgellons biofilm study with a 2026 metagenomic analysis, featuring a hypopigmented lesion with fine fibers, Helicobacter imagery, and a phylogenetic tree.

In 2019, researchers reported Helicobacter pylori-associated findings in most of the Morgellons dermatological specimens they examined and described the organism alongside Borrelia burgdorferi in mixed biofilm-like aggregates. Seven years later, an untargeted metagenomic study reported broad Proteobacteria-associated patterns in Morgellons lesion material. Because H. pylori was historically classified among the Epsilonproteobacteria, the newer result appeared to point back toward the same broad bacterial territory. If that resemblance represented genuine independent convergence, it could have been one of the most intriguing developments in Morgellons research. I went looking for how far the evidence actually reached.

Read more